0
0 (0%)
BeiGene, Ltd. [BEIGF]
Source:
Company Overview
Beigene, Ltd is a leading global oncology company discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide.
| Country | United States |
| Headquarters | grand cayman |
| Phone Number | 13459494123 |
| Industry | manufacturing |
| CEO | John V. Oyler |
| Website | www.beigene.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $3,810.2 |
| Operating Profit | $-568.2 |
| Net Income | $-644.8 |
| Net Cash | $-547.2 |
Profit Ratios
| Gross Margin | $3,216.2 |
| Operating Margin | -14.9 |
| Profit as % of Revenues | -498.8% |
| Profit as % of Assets | -11% |
| Profit as % of Stockholder Equity | -19.4% |
Management Effectiveness
| Return on Equity | -19.4% |
| Return on Assets | -10.9% |
| Turnover Ratio | 65% |
| EBITA | $-568.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $5,920.9 |
| Total Liabilities | $2,588.7 |
| Operating Cash Flow | $-140.6 |
| Investing Cash Flow | $-548.4 |
| Financing Cash Flow | $193.4 |
